Overview
The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.
Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
Testimonials
The DIA is an opportunity for veterans and freshmen alike to learn and better understand the landscape of the current regulatory world, and participate in building a future where patients, physicians, regulators, payer and the industry can live healthier. -2019 Attendee
A fantastic venue for exchange of new information, clarification on evolving regulations and future directions. -2019 Attendee
Program Committee
-
Marc Poitras, PhD, MBA • Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada -
Lisa Chartrand • Director, Regulatory Strategy and Policy
Hoffmann-La Roche Limited, Canada -
Samar Darwish, MBA, MSc • Director, Drug Regulatory Affairs
Boehringer Ingelheim, Canada -
Judith Mergl, MSc • Director, Regulatory Affairs and Operational Services
AbbVie Corporation, Canada -
Melissa Hunt, MSc • Director
Health Canada, Canada -
Yatika Kohli, PhD, MBA • Executive Director - Global Regulatory Affairs
NoNO Inc, Canada -
Kristin Willemsen, MS • Vice President, Scientific & Regulatory Affairs
Food, Health & Consumer Products of Canada, Canada -
Fiona M Frappier, PhD • Manager
Health Canada, Canada -
Rania Mouchantaf, PhD • Associate Director
Health Canada, Canada
